A Study to Understand How the Study Medicine Dazukibart Works in People With Idiopathic Inflammatory Myopathies
Clinical trial NCT06698796 · RECRUITING
Trial details
- NCT number
- NCT06698796
- Sponsor
- Pfizer
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2025-01-22
- Primary completion
- 2027-11-25
- Enrollment
- 211
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.